Evidence map›Paper›PMID 39834986›Full record

ArticleCureus2024

Massive Splenomegaly in Felty's Syndrome: A Case Report.

Laura N Soares, Juliana M Sternlicht, Nicole Jensen, Tomasia Jennyfer T de Aguiar, Marcelo Vincenzo Sarno Filho, Giovanna Caruso, Bruno Alvim C Araujo, Milton Glezer, Arnaldo Lichtenstein, Luiza Parra and 1 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laura N SoaresInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Juliana M SternlichtInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Nicole JensenInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Tomasia Jennyfer T de AguiarInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Marcelo Vincenzo Sarno FilhoInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Giovanna CarusoGeneral Practice, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Bruno Alvim C AraujoInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Milton GlezerInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Arnaldo LichtensteinInternal Medicine, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Luiza ParraOphthalmology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.
Luis R ZogaibGeneral Practice, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, BRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Felty's syndrome (FS) is a rare and complex condition most commonly seen as a complication of longstanding rheumatoid arthritis (RA), characterized by a triad of RA, splenomegaly, and neutropenia. Diagnosing FS can be challenging due to its diverse clinical presentations and overlap with other hematologic and autoimmune conditions. We report a 47-year-old male with a history of severe anemia, recurrent blood transfusions, and a chronic leg ulcer. In 2024, he presented with significant weight loss, polyarthralgia, and splenomegaly, prompting concern for a hematologic malignancy. Laboratory findings included elevated beta-2-microglobulin and positive antinuclear antibodies, raising suspicion of lymphoma or other malignancies. Extensive testing ruled out hematologic malignancies and schistosomiasis, and further investigation suggested FS. He was started on prednisone, filgrastim, and methotrexate, leading to substantial clinical improvement, including reduction of joint symptoms, spleen size, and improvement of the leg ulcer. This case highlights the diagnostic complexities of FS, especially in the absence of a prior RA diagnosis. FS should be considered in the differential diagnosis when encountering unexplained splenomegaly and neutropenia, even without a history of chronic RA. Early recognition and treatment can significantly improve patient outcomes. FS, though rare, should be considered in patients presenting with systemic symptoms, cytopenias, and splenomegaly. A thorough diagnostic workup is crucial to differentiate FS from other conditions, particularly hematologic malignancies. This case underscores the importance of prompt diagnosis and treatment to achieve favorable clinical outcomes.

Indexed as

chronic ulcerdiagnostic challengesfelty’s syndromeneutropeniarheumatoid arthritissplenomegaly

Identifiers

PMID39834986
PMCPMC11743570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.